| Date | Time | Source | Headline | Symbol | Company |
| 03/04/2011 | 9:56AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/02/2011 | 2:32PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/01/2011 | 9:00AM | Business Wire | Impax Laboratories to Present at the Cowen & Co. 31st Annual Health Care Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/28/2011 | 5:13PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/25/2011 | 1:15PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/25/2011 | 9:00AM | Business Wire | Impax Laboratories to Present at the RBC Capital Markets’ Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/24/2011 | 10:35AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/24/2011 | 7:00AM | Business Wire | Impax Laboratories Reports Fourth Quarter and Record Full Year 2010 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/18/2011 | 9:00AM | Business Wire | Impax Laboratories Receives Final FDA Approval for Generic Adoxa® 150 mg Capsules | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/17/2011 | 2:38PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/16/2011 | 12:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/14/2011 | 1:51PM | Edgar (US Regulatory) | Schedule 13G | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/04/2011 | 3:44PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/03/2011 | 2:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/27/2011 | 11:00AM | Business Wire | Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2010 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/25/2011 | 5:50PM | Dow Jones News | Watson Files Patent Challenge For Cholesterol Drug WelChol | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/18/2011 | 5:56PM | Business Wire | Impax Laboratories Corrects Inaccurate Information about Product Pipeline Opportunities Discussed in Several Financial Articl... | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/11/2011 | 12:38PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/04/2011 | 10:00AM | Business Wire | Impax Laboratories to Present at the J.P. Morgan Annual Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/29/2010 | 9:15AM | Business Wire | Impax Laboratories Receives Final FDA Approval for Generic Doryx® 75 and 100mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/21/2010 | 2:28PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/16/2010 | 9:29AM | Dow Jones News | Glaxo, Impax Reach Licensing Pact for Parkinson's Treatment | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/16/2010 | 8:44AM | Dow Jones News | GlaxoSmithKline Licensed To Commercialize IPX066 Throughout The World | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/16/2010 | 8:00AM | Business Wire | GlaxoSmithKline & Impax Pharmaceuticals Enter Global Agreement to Develop & Commercialize a late stage compound for Parkinson... | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/13/2010 | 8:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/13/2010 | 6:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/06/2010 | 3:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/03/2010 | 5:00PM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to INTUNIVTM, 4 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/03/2010 | 2:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/03/2010 | 7:36AM | Dow Jones News | Shire Files Lawsuit Against Impax And Watson | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |